相关实验视频
Updated: Jun 14, 2025
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
治疗宫癌放射治疗后的二次子宫恶性瘤:基于SEER数据库的研究
Xiaojing Tong1, Yunyun Xiao2, Haozhen Li3
1Department of Gynecology, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang, 110042, Liaoning Province, China.
BMC women's health
|August 29, 2024
概括
在宫癌放射治疗后可能出现二次子宫恶性瘤. 与化疗相结合的手术为这些患者提供了优越的生存结果,与其他治疗相比.
科学领域:
- 妇科瘤学 妇科瘤学
- 辐射瘤学 辐射瘤学
- 癌症流行病学 癌症流行病学
背景情况:
- 放射治疗是宫癌的首要治疗方法,但可能导致像二次瘤这样的长期并发症.
- 二次性子宫恶性瘤是宫癌患者暴露于辐射后的一个已知的风险.
研究的目的:
- 调查宫癌放射治疗后发生二次子宫恶性瘤的患者的最佳治疗方式.
- 分析基于辐射诱导子宫癌的治疗干预措施的生存结果.
主要方法:
- 对监测,流行病学和最终结果 (SEER) 数据库的回顾性分析.
- 包括被诊断为宫癌的患者,然后在≥1年后出现子宫恶性病.
- 利用COX回归和Kaplan-Meier生存分析来确定预后因素.
主要成果:
- 确定了142名患有宫癌治疗后二级子宫恶性瘤的患者.
- 手术显著改善了二次性子宫恶性瘤放射治疗后患者的预后 (HR 0.374).
- 与其他治疗方式相比,手术和化疗的结合显示出更高的生存率 (HR 0.251).
结论:
- 治疗方式在宫癌后放射治疗后的二次子宫恶性瘤中显著影响存活率.
- 手术加上化疗是最有效的治疗策略,产生更好的生存结果.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493